Skip to main content

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics was previously published as Anti-Cancer Drug Design.

Publisher: Cognizant Communication Corporation

Volume 12, Number 5, 2001

Research Articles

Indoloquinoxaline Compounds That Selectively Antagonize P-Glycoprotein
pp. 219-229(11)
Authors: Smith, C.D.; Myers, C.B.; Zilfou, J.T.; Smith, S.N.; Lawrence, D.S.


Differences in the Induction of DNA Damage, Cell Cycle Arrest, and Cell Death by 5-Fluorouracil and Antifolates
pp. 231-239(9)
Authors: Backus, H.H.J.; Pinedo, H.M.; Wouters, D.; Kuiper, C.M.; Jansen, G.; van Groeningen, C.J.; Peters, G.J.


Angiogenic and Immune Parameters During Recombinant Interferon-α2b Adjuvant Treatment in Patients With Melanoma
pp. 241-251(11)
Authors: Dréau, D.; Foster, M.; Hogg, M.; Swiggett, J.; Holder, W.D.; White, R.L.


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more